Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies

Overview of attention for article published in Journal for Immunotherapy of Cancer, April 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 25 X posts from 10 X users, with an upper bound of 37,385 followers.

Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies. https://t.co/eR4fMpkkej

#JITC Research: Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies https://t.co/Cf8QrgeQaB https://t.co/48oXkrjecu

RT @sitcancer: #JITC Research: Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies https:/…

#JITC Research: Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies https://t.co/Cf8QrgeQaB https://t.co/KPfR5mFn9v

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 21 additional X posts.